Delayed legislation may hurt settlement of medical reform program.

The revised bill of the pharmaceutical affairs law now holding at the National Assembly seems not to pass through the National Assembly during the current extraordinary session.

If the bill fails to pass this time, the medical and pharmacy role separation program may not smoothly settle down leaving many problems behind including the business link between pharmacies and medical institutes, t...